Aptiv PLC

APTV

Held by 1 specialist biotech fund

Fund Holdings

AI Signal

**Signal Note: Eventide/APTV Position** This signal appears inconsistent with typical biotech thesis—Aptiv is an automotive supplier (autonomous vehicles, electrification), not a drug developer.

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Eventide Asset ManagementNEWFeb 13, 2026

Shares: 11,629Value: $894K

**Signal Note: Eventide/APTV Position** This signal appears inconsistent with typical biotech thesis—Aptiv is an automotive supplier (autonomous vehicles, electrification), not a drug developer. Eventide's core competency is healthcare/biotech investing, suggesting either: (1) portfolio diversification into adjacent tech, (2) conviction on autonomous vehicle safety as a healthcare enabler, or (3) data error. Without disclosed rationale, the $894K position warrants clarification on whether this represents a strategic pivot or isolated tactical trade.

More APTV Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

CPRT1 fund DECK1 fund LITE1 fund NTAP1 fund GPI1 fund IMMX1 fund PI1 fund UNP1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: